FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022983359> ?p ?o ?g. }

• W2022983359 endingPage "2668" @default.
• W2022983359 startingPage "2658" @default.
• W2022983359 abstract "Sequestration in the bone marrow niche may allow leukemic stem cells to evade exposure to drugs. Because the CXCR4/SDF-1 axis is an important mechanism of leukemic stem cell interaction with marrow stroma, we tested whether plerixafor, an antagonist of CXCR4, may dislodge chronic myeloid leukemia (CML) cells from the niche, sensitizing them to tyrosine kinase inhibitors. We initially treated mice with retrovirally induced CML-like disease with imatinib plus plerixafor. Plerixafor mobilized CXCR4(+) cells, but no difference was observed in leukemia burden, possibly reflecting insufficient disease control by imatinib. In a second series of experiments, we tested the combination of plerixafor with dasatinib in the same as well as an attenuated CML model. Despite much improved leukemia control, plerixafor failed to reduce leukemia burden over dasatinib alone. In addition, mice receiving plerixafor had an increased incidence of neurologic symptoms in association with CNS infiltration by BCR-ABL-expressing cells. We conclude that plerixafor is ineffective in reducing leukemia burden in this model but promotes CNS infiltration. Beneficial effects of combining tyrosine kinase inhibitors with plerixafor may be observed in a situation of minimal residual disease, but caution is warranted when disease control is incomplete." @default.
• W2022983359 created "2016-06-24" @default.
• W2022983359 creator A5010886409 @default.
• W2022983359 creator A5013204157 @default.
• W2022983359 creator A5020784702 @default.
• W2022983359 creator A5041829729 @default.
• W2022983359 creator A5045437866 @default.
• W2022983359 creator A5045775287 @default.
• W2022983359 creator A5054155535 @default.
• W2022983359 creator A5076074507 @default.
• W2022983359 creator A5090802229 @default.
• W2022983359 date "2012-09-27" @default.
• W2022983359 modified "2023-10-18" @default.
• W2022983359 title "Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML" @default.
• W2022983359 cites W1528751727 @default.
• W2022983359 cites W1965553215 @default.
• W2022983359 cites W1966214427 @default.
• W2022983359 cites W1974607766 @default.
• W2022983359 cites W1978466041 @default.
• W2022983359 cites W1987239635 @default.
• W2022983359 cites W1987930421 @default.
• W2022983359 cites W2013094135 @default.
• W2022983359 cites W2014316424 @default.
• W2022983359 cites W2016656445 @default.
• W2022983359 cites W2022029029 @default.
• W2022983359 cites W2029254213 @default.
• W2022983359 cites W2035614371 @default.
• W2022983359 cites W2043046186 @default.
• W2022983359 cites W2046548078 @default.
• W2022983359 cites W2051517030 @default.
• W2022983359 cites W2052308956 @default.
• W2022983359 cites W2054353525 @default.
• W2022983359 cites W2058450187 @default.
• W2022983359 cites W2058554403 @default.
• W2022983359 cites W2062325286 @default.
• W2022983359 cites W2063918186 @default.
• W2022983359 cites W2064831267 @default.
• W2022983359 cites W2074740555 @default.
• W2022983359 cites W2079517811 @default.
• W2022983359 cites W2085269642 @default.
• W2022983359 cites W2091552147 @default.
• W2022983359 cites W2098785293 @default.
• W2022983359 cites W2107268345 @default.
• W2022983359 cites W2124090816 @default.
• W2022983359 cites W2124514001 @default.
• W2022983359 cites W2127006638 @default.
• W2022983359 cites W2141648366 @default.
• W2022983359 cites W2150833007 @default.
• W2022983359 cites W2168142681 @default.
• W2022983359 cites W2168746423 @default.
• W2022983359 cites W2289173177 @default.
• W2022983359 cites W2326572877 @default.
• W2022983359 cites W2334238127 @default.
• W2022983359 cites W327275585 @default.
• W2022983359 doi "https://doi.org/10.1182/blood-2011-05-355396" @default.
• W2022983359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3460687" @default.
• W2022983359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22889761" @default.
• W2022983359 hasPublicationYear "2012" @default.
• W2022983359 type Work @default.
• W2022983359 sameAs 2022983359 @default.
• W2022983359 citedByCount "34" @default.
• W2022983359 countsByYear W20229833592013 @default.
• W2022983359 countsByYear W20229833592014 @default.
• W2022983359 countsByYear W20229833592015 @default.
• W2022983359 countsByYear W20229833592016 @default.
• W2022983359 countsByYear W20229833592017 @default.
• W2022983359 countsByYear W20229833592018 @default.
• W2022983359 countsByYear W20229833592019 @default.
• W2022983359 countsByYear W20229833592020 @default.
• W2022983359 countsByYear W20229833592021 @default.
• W2022983359 countsByYear W20229833592023 @default.
• W2022983359 crossrefType "journal-article" @default.
• W2022983359 hasAuthorship W2022983359A5010886409 @default.
• W2022983359 hasAuthorship W2022983359A5013204157 @default.
• W2022983359 hasAuthorship W2022983359A5020784702 @default.
• W2022983359 hasAuthorship W2022983359A5041829729 @default.
• W2022983359 hasAuthorship W2022983359A5045437866 @default.
• W2022983359 hasAuthorship W2022983359A5045775287 @default.
• W2022983359 hasAuthorship W2022983359A5054155535 @default.
• W2022983359 hasAuthorship W2022983359A5076074507 @default.
• W2022983359 hasAuthorship W2022983359A5090802229 @default.
• W2022983359 hasBestOaLocation W20229833592 @default.
• W2022983359 hasConcept C126322002 @default.
• W2022983359 hasConcept C129470790 @default.
• W2022983359 hasConcept C13373296 @default.
• W2022983359 hasConcept C203014093 @default.
• W2022983359 hasConcept C2777583451 @default.
• W2022983359 hasConcept C2778461978 @default.
• W2022983359 hasConcept C2778729363 @default.
• W2022983359 hasConcept C2778828106 @default.
• W2022983359 hasConcept C2779536868 @default.
• W2022983359 hasConcept C28328180 @default.
• W2022983359 hasConcept C3019892230 @default.
• W2022983359 hasConcept C502942594 @default.
• W2022983359 hasConcept C54355233 @default.
• W2022983359 hasConcept C71924100 @default.
• W2022983359 hasConcept C86803240 @default.
• W2022983359 hasConcept C8891405 @default.

• next